Cargando…

Temporal changes of COVID-19 pneumonia by mass evaluation using CT: a retrospective multi-center study

BACKGROUND: Coronavirus disease 2019 (COVID-19) has widely spread worldwide and caused a pandemic. Chest CT has been found to play an important role in the diagnosis and management of COVID-19. However, quantitatively assessing temporal changes of COVID-19 pneumonia over time using CT has still not...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chao, Huang, Peiyu, Wang, Lihua, Shen, Zhujing, Lin, Bin, Wang, Qiyuan, Zhao, Tongtong, Zheng, Hanpeng, Ji, Wenbin, Gao, Yuantong, Xia, Junli, Cheng, Jianmin, Ma, Jianbing, Liu, Jun, Liu, Yongqiang, Su, Miaoguang, Ruan, Guixiang, Shu, Jiner, Ren, Dawei, Zhao, Zhenhua, Yao, Weigen, Yang, Yunjun, Liu, Bo, Zhang, Minming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475384/
https://www.ncbi.nlm.nih.gov/pubmed/32953735
http://dx.doi.org/10.21037/atm-20-4004
Descripción
Sumario:BACKGROUND: Coronavirus disease 2019 (COVID-19) has widely spread worldwide and caused a pandemic. Chest CT has been found to play an important role in the diagnosis and management of COVID-19. However, quantitatively assessing temporal changes of COVID-19 pneumonia over time using CT has still not been fully elucidated. The purpose of this study was to perform a longitudinal study to quantitatively assess temporal changes of COVID-19 pneumonia. METHODS: This retrospective and multi-center study included patients with laboratory-confirmed COVID-19 infection from 16 hospitals between January 19 and March 27, 2020. Mass was used as an approach to quantitatively measure dynamic changes of pulmonary involvement in patients with COVID-19. Artificial intelligence (AI) was employed as image segmentation and analysis tool for calculating the mass of pulmonary involvement. RESULTS: A total of 581 confirmed patients with 1,309 chest CT examinations were included in this study. The median age was 46 years (IQR, 35–55; range, 4–87 years), and 311 (53.5%) patients were male. The mass of pulmonary involvement peaked on day 10 after the onset of initial symptoms. Furthermore, the mass of pulmonary involvement of older patients (>45 years) was significantly severer (P<0.001) and peaked later (day 11 vs. day 8) than that of younger patients (≤45 years). In addition, there were no significant differences in the peak time (day 10 vs. day 10) and median mass (P=0.679) of pulmonary involvement between male and female. CONCLUSIONS: Pulmonary involvement peaked on day 10 after the onset of initial symptoms in patients with COVID-19. Further, pulmonary involvement of older patients was severer and peaked later than that of younger patients. These findings suggest that AI-based quantitative mass evaluation of COVID-19 pneumonia hold great potential for monitoring the disease progression.